{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:21:10Z","timestamp":1787606470919,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["KJ2021ZD0097"],"award-info":[{"award-number":["KJ2021ZD0097"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32485","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:21:28Z","timestamp":1717597288000},"page":"e32485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The correlation between the MYBL2\/CDCA8 signaling pathway of malignant melanoma"],"prefix":"10.1016","volume":"10","author":[{"given":"Chen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e32485_bib1","first-page":"163","article-title":"Melanoma development: current knowledge on melanoma pathogenesis","volume":"27","author":"Lugovi\u0107-Mihi\u0107","year":"2019","journal-title":"Acta Dermatovenerol. Croat."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32485_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","article-title":"Malignant melanoma: skin cancer-diagnosis, prevention, and treatment","volume":"30","author":"Ahmed","year":"2020","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32485_bib3","first-page":"973","article-title":"Principles of surgical treatment of malignant melanoma","volume":"94","author":"Kimbrough","year":"2014","journal-title":"Surg. Clin."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32485_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/cells10020327","article-title":"Malignant melanoma of the gastrointestinal tract: symptoms, diagnosis, and current treatment options","volume":"5","author":"Kohoutova","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32485_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4149\/neo_2015_055","article-title":"Expression of CDCA8 correlates closely with FOXM1 in breast cancer: public microarray data analysis and immunohistochemical study","volume":"62","author":"Jiao","year":"2015","journal-title":"Neoplasma"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32485_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/CMR.0000000000000697","article-title":"Identification of prognostic mRNAs in metastatic cutaneous melanoma","volume":"30","author":"Lee","year":"2020","journal-title":"Melanoma Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32485_bib7","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1111\/jocd.15091","article-title":"Regulators CDCA8 as potential targets and biomarkers for the prognosis of human skin cutaneous melanoma","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32485_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13578-023-01006-6","article-title":"TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K\/Akt pathway","volume":"29","author":"Guo","year":"2023","journal-title":"Cell Biosci."},{"issue":"34","key":"10.1016\/j.heliyon.2024.e32485_bib9","article-title":"CDCA8 expression and its clinical relevance in patients with bladder cancer","volume":"97","author":"Bi","year":"2018","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32485_bib10","first-page":"404","article-title":"Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis","volume":"43","author":"Ci","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e32485_bib11","article-title":"LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR Axis","volume":"2","author":"Mu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32485_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10735-020-09920-6","article-title":"The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer","volume":"52","author":"Li","year":"2021","journal-title":"J. Mol. Histol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32485_bib13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1872-034X.2008.00324.x","article-title":"Activation of B-Myb by E2F1 in hepatocellular carcinoma","volume":"38","author":"Nakajima","year":"2008","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32485_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajhg.2016.02.021","article-title":"Genomic characterization of esophageal squa mous cell carcinoma reveals critical genes underlying tumorigenesis and poor pro gnosis","volume":"98","author":"Qin","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32485_bib15","first-page":"389","article-title":"CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer","volume":"11","author":"Qi","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32485_bib16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/cancers13061408","article-title":"A MAPK\/miR-29 Axis suppresses melanoma by targeting MAFG and MYBL2","volume":"13","author":"Vera","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32485_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","article-title":"Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"1","author":"Coit","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32485_bib18","first-page":"495","volume":"1","author":"Arnold","year":"2022","journal-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040"},{"issue":"19\u201320","key":"10.1016\/j.heliyon.2024.e32485_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1101\/gad.329771.119","article-title":"Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities","volume":"33","author":"Rambow","year":"2019","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32485_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/life13061369","article-title":"Clinical, dermoscopic, and histological characteristics of melanoma patients according to the age groups: a retrospective observational study","volume":"13","author":"S\u0142owi\u0144ska","year":"2023","journal-title":"Life"},{"issue":"174","key":"10.1016\/j.heliyon.2024.e32485_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lfs.2017.02.011","article-title":"Towards therapeutic advances in melanoma management: an overview","volume":"1","author":"Singh","year":"2017","journal-title":"Life Sci."},{"issue":"6371","key":"10.1016\/j.heliyon.2024.e32485_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.heliyon.2024.e32485_bib23","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/IJGM.S351638","article-title":"MYBL2 is a novel independent prognostic biomarker and correlated with immune infiltrates in prostate cancer","volume":"15","author":"Jiao","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32485_bib24","first-page":"2765","article-title":"Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma","volume":"19","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"issue":"41","key":"10.1016\/j.heliyon.2024.e32485_bib25","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/s41388-022-02456-x","article-title":"MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3","volume":"41","author":"Liu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e32485_bib26","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1158\/0008-5472.CAN-06-4705","article-title":"Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis","volume":"67","author":"Hayama","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32485_bib27","article-title":"MYBL2 amplification in breast cancer: molecular mechanisms and therapeutic potential","volume":"874","author":"Bayley","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.heliyon.2024.e32485_bib28","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1158\/0008-5472.CAN-18-0273","article-title":"MYBL2 supports DNA Double strand break repair in hematopoietic stem cells","volume":"78","author":"Bayley","year":"2018","journal-title":"Cancer Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024085165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024085165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:32:21Z","timestamp":1787603541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024085165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024085165"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32485","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The correlation between the MYBL2\/CDCA8 signaling pathway of malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32485"}}